Previous close | 65.20 |
Open | 65.32 |
Bid | 65.47 x 200 |
Ask | 65.51 x 200 |
Day's range | 64.97 - 65.89 |
52-week range | 64.63 - 87.87 |
Volume | |
Avg. volume | 7,425,481 |
Market cap | 81.689B |
Beta (5Y monthly) | 0.20 |
PE ratio (TTM) | 181.97 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 3.08 (4.70%) |
Ex-dividend date | 14 Jun 2024 |
1y target est | N/A |
Gilead Sciences, Inc. (NASDAQ:GILD) Q1 2024 Earnings Call Transcript April 25, 2024 Gilead Sciences, Inc. beats earnings expectations. Reported EPS is $-1.32, expectations were $-1.49. Gilead Sciences, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, everyone, and […]
Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Gilead Sciences ( NASDAQ:GILD ) First Quarter 2024 Results Key Financial Results Revenue: US$6.69b (up 5.3% from 1Q...